172 related articles for article (PubMed ID: 6160402)
21. Junin virus monoclonal antibodies: characterization and cross-reactivity with other arenaviruses.
Sanchez A; Pifat DY; Kenyon RH; Peters CJ; McCormick JB; Kiley MP
J Gen Virol; 1989 May; 70 ( Pt 5)():1125-32. PubMed ID: 2471803
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to Lassa and Lassa-like viruses in man and mammals in the Central African Republic.
Georges AJ; Gonzalez JP; Abdul-Wahid S; Saluzzo JF; Meunier DM; McCormick JB
Trans R Soc Trop Med Hyg; 1985; 79(1):78-9. PubMed ID: 2986324
[TBL] [Abstract][Full Text] [Related]
23. Indirect solid-phase immunosorbent assay for detection of arenavirus antigens and antibodies.
Ivanov AP; Rezapkin GV; Dzagurova TK; Tkachenko EA
Acta Virol; 1984 May; 28(3):240-5. PubMed ID: 6148001
[TBL] [Abstract][Full Text] [Related]
24. Current progress towards vaccines for arenavirus-caused diseases.
Clegg JC
Vaccine; 1992; 10(2):89-95. PubMed ID: 1311492
[TBL] [Abstract][Full Text] [Related]
25. Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses.
Rodrigo WW; de la Torre JC; Martínez-Sobrido L
J Virol; 2011 Feb; 85(4):1684-95. PubMed ID: 21123370
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of monoclonal antibodies against Lassa virus].
Vladyko AS; Bystrova SI; Lemeshko NN; Lukashevich IS
Mol Gen Mikrobiol Virusol; 1987 May; (5):37-40. PubMed ID: 2441254
[TBL] [Abstract][Full Text] [Related]
27. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
[TBL] [Abstract][Full Text] [Related]
28. Assessing cross-reactivity of Junín virus-directed neutralizing antibodies.
Leske A; Waßmann I; Schnepel K; Shifflett K; Holzerland J; Bostedt L; Bohn P; Mettenleiter TC; Briggiler AM; Brignone J; Enria D; Cordo SM; Hoenen T; Groseth A
Antiviral Res; 2019 Mar; 163():106-116. PubMed ID: 30668977
[TBL] [Abstract][Full Text] [Related]
29. Recovery of a Lassa-related arenavirus in Zimbabwe.
Johnson KM; Taylor P; Elliott LH; Tomori O
Am J Trop Med Hyg; 1981 Nov; 30(6):1291-3. PubMed ID: 7034562
[TBL] [Abstract][Full Text] [Related]
30. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit RIG-I-like receptor-dependent interferon production.
Xing J; Ly H; Liang Y
J Virol; 2015 Mar; 89(5):2944-55. PubMed ID: 25552708
[TBL] [Abstract][Full Text] [Related]
31. The role of the vascular endothelium in arenavirus haemorrhagic fevers.
Kunz S
Thromb Haemost; 2009 Dec; 102(6):1024-9. PubMed ID: 19967131
[TBL] [Abstract][Full Text] [Related]
32. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
33. A short history of Lassa fever: the first 10-15 years after discovery.
Monath TP
Curr Opin Virol; 2019 Aug; 37():77-83. PubMed ID: 31323506
[TBL] [Abstract][Full Text] [Related]
34. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus.
Walker DH; Johnson KM; Lange JV; Gardner JJ; Kiley MP; McCormick JB
J Infect Dis; 1982 Sep; 146(3):360-8. PubMed ID: 6286795
[TBL] [Abstract][Full Text] [Related]
35. Standardization of a plaque assay for Lassa virus.
Tomori O; Johnson KM; Kiley MP; Elliott LH
J Med Virol; 1987 May; 22(1):77-89. PubMed ID: 3585290
[TBL] [Abstract][Full Text] [Related]
36. Zoonotic aspects of arenavirus infections.
Charrel RN; de Lamballerie X
Vet Microbiol; 2010 Jan; 140(3-4):213-20. PubMed ID: 19748747
[TBL] [Abstract][Full Text] [Related]
37. Immune response to vaccination against Argentine hemorrhagic Fever in an area where different arenaviruses coexist.
Ambrosio AM; Riera LM; Saavedra Mdel C; Sabattini MS
Viral Immunol; 2006; 19(2):196-201. PubMed ID: 16817762
[TBL] [Abstract][Full Text] [Related]
38. Mucosal arenavirus infection of primates can protect them from lethal hemorrhagic fever.
Rodas JD; Lukashevich IS; Zapata JC; Cairo C; Tikhonov I; Djavani M; Pauza CD; Salvato MS
J Med Virol; 2004 Mar; 72(3):424-35. PubMed ID: 14748066
[TBL] [Abstract][Full Text] [Related]
39. Cell entry by human pathogenic arenaviruses.
Rojek JM; Kunz S
Cell Microbiol; 2008 Apr; 10(4):828-35. PubMed ID: 18182084
[TBL] [Abstract][Full Text] [Related]
40. Properties and characterization of monoclonal antibodies to Tacaribe virus.
Howard CR; Lewicki H; Allison L; Salter M; Buchmeier MJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1383-95. PubMed ID: 2410550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
